Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bi-weekly liposomal paclitaxel plus nedaplatin in advanced lung squamous cell carcinoma
ChiCTR-OIN-17011423Phase 2Not yet recruiting
- Sponsor
- The Fifth Affiliated Hospital of Sun Yat-sen University
- Start
- Jun 2017
- Modality
- DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Liposomes → Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of liposomal paclitaxel and nedaplatin in Pulmonary squamous cell carcinoma, sponsored by The Fifth Affiliated Hospital of Sun Yat-sen University. Primary endpoint: response rate. Planned start Jun 2017; status: not yet recruiting.
02
Drugs
liposomal paclitaxelnedaplatin
03
Conditions
Pulmonary squamous cell carcinoma
Beyond the preview
Go deeper on ChiCTR-OIN-17011423.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-17011423.